Editorial review on Vol. 7 No. 1

Zhiling Yu

doi:10.24294/ti.v7.i1.2896

How to cite

Loading...

Export citation

Endnote/Zotero/Mendeley (RIS)› BibTeX›

Copyright & License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

License

Trends in Immunotherapy (TI) publishes accepted manuscripts under Creative Commons Attribution 4.0 International (CC BY 4.0). Authors who submit their papers for publication by TI agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for any purpose, including commercial use. As long as the author and original source are properly cited, anyone may copy, redistribute, reuse, and transform the content.

Editorial

Editorial review on Vol. 7 No. 1

Zhiling Yu

Received: 05 September 2024

Published: 25 July 2023

Abstract

References

1. Sakshi, Mazumder R, Monika, et al. Novel approaches for allergen-specific immunotherapy—An overview. Trends in Immunotherapy 2023; 7(1): 2026. doi: 10.24294/ti.v7.i1.2026.
2. Zhang F, Lv Y, Zhou X, et al. Novel targeted cancer therapy based on β-hydroxybutyric acid associated energy metabolism regulated by intestinal flora. Trends in Immunotherapy 2023; 7(1): 2160. doi: 10.24294/ti.v7.i1.2160.
3. Pandey P, Khan F, Yadav K, et al. Screen natural terpenoids to identify potential Jab1 inhibitors for treating breast cancer. Trends in Immunotherapy 2023; 7(1): 2055. doi: 10.24294/ti.v7.i1.2055.
4. Sivalingam D, Singh M. Targeting the ACE2 receptor using nanomedicine: Novel approach to lung cancer therapy. Trends in Immunotherapy 2023; 7(1): 1838. doi: 10.24294/ti.v7.i1.1838.
5. Singh N, Mazumder R, Monika, et al. Development in therapeutic strategies for allergic conjunctivitis. Trends in Immunotherapy 2023; 7(1): 2025. doi: 10.24294/ti.v7.i1.2025.
6. Engin MMN, Özdemir Ö. Current mechanisms in the pathogenesis of lung fibrosis. Trends in Immunotherapy 2023; 7(1): 2028. doi: 10.24294/ti.v7.i1.2028.
7. Mohamed R, Ramli MM, Reshak AH, et al. Revolutionizing cancer treatment by boosting dendritic cell vaccine efficacy with graphene oxide. Trends in Immunotherapy 2023; 7(1): 2039. doi: 10.24294/ti.v7.i1.2039.
8. Takkella BK, Anusha NV, Sujanamulk B, et al. Perspective of 3D printing in dentistry—Exploring the new horizon. Trends in Immunotherapy 2023; 7(1): 2133. doi: 10.24294/ti.v7.i1.2133.
9. Shiva S, Khanzadeh S, Rashidi F, Lucke-Wold B. Association of anticardiolipin antibodies with epilepsy in children. Trends in Immunotherapy 2023; 7(1): 2021. doi: 10.24294/ti.v7.i1.2021.